Viewing nowCombinationEmpavex 12.5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Seoul Pharmaceutical Co., Ltd.

MFDS item code 202501701 · Approved 2025.07.08 · Insurance code 652904760
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication works by combining the two ingredients, Empagliflozin and Metformin, to supplement dietary and exercise therapy, assisting in blood sugar control for adults with Type 2 diabetes. It can be used, particularly for patients whose blood sugar is not adequately controlled and have cardiovascular disease; however, guidance from a specialist regarding related cardiovascular events must be followed. This medication effectively improves blood sugar control and aids in the treatment of Type 2 diabetes.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. No dose adjustment is required in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use 2. Patients in Whom the Medicine Must Not Be Used, item 2)). Renal function and the risk of volume depletion should be considered in patients aged 75 years or older.
This medication is used for the treatment of diabetes, helping to lower blood sugar. However, severe lactic acidosis, a rare side effect, can occur, necessitating caution. When used in conjunction with other diabetes treatments, there is a risk of hypoglycemia, so care should be taken. Patients with impaired kidney function or acute disease should not use this medication. Additionally, women who are pregnant or breastfeeding should not take this medication. Regular kidney function tests should be performed while taking this medication, and it may be temporarily discontinued during periods of dehydration, severe infection, or before and after surgery. Patients at risk of fluid loss or elderly patients should be especially cautious when using this medication. Side effects such as gastrointestinal disturbances, urinary tract infections, genital infections, increased urination may occur; if symptoms arise, consult a physician. Symptoms of hypoglycemia, where blood sugar levels drop too low, can also appear; it is advisable to eat regularly and avoid sudden exercise or drinking alcohol. This medication should be used cautiously in patients with liver dysfunction, as liver function abnormalities may occasionally occur. Furthermore, when undergoing tests involving iodinated contrast agents, this medication should be stopped before and after the tests, and resumed only after confirming normal kidney function. Alcohol intake should be avoided while taking this medication as it may increase the risk of lactic acidosis. Patients should ensure adequate fluid intake while taking this medication and report any unusual symptoms to medical personnel immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help keep the medication effective for a longer period.
A pinkish-white, biconvex, oval film-coated tablet
60 tablets/bottle, 60 tablets/box [10 tablets/PTP x 6]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Seoul Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.